This inventor holds 5 USPTO granted patents. Top assignee: Bayer Aktiengesellschaft. Active years: 1976-1995.
Location History:
- Wuppertal-Elberfeld, DE (1976)
- Wuppertal, DE (1976 - 1995)
Company Filing History:
Years Active: 1976-1995
Title: Gerd Aichinger: Innovator in Antiretroviral Research
Introduction
Gerd Aichinger is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiretroviral agents. With a total of 5 patents to his name, Aichinger's work has had a meaningful impact on medical research.
Latest Patents
Aichinger's latest patents include innovative compounds such as 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes. This invention relates to processes for their preparation and their use as inhibitors of reverse transcriptase, specifically as antiretroviral agents. Another significant patent involves aminoalkyl-substituted 5,6-dihydro-dibenz[b,e]azepine-6,11-dione-11-oximes, which also focuses on their preparation and application as antiretroviral agents.
Career Highlights
Gerd Aichinger is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to explore and develop innovative solutions in the field of medicine. Aichinger's research has been pivotal in advancing treatments for viral infections.
Collaborations
Throughout his career, Aichinger has collaborated with esteemed colleagues such as Eckart Kranz and Axel Haberkorn. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical agents.
Conclusion
Gerd Aichinger's contributions to the field of antiretroviral research exemplify the importance of innovation in medicine. His patents and collaborations continue to pave the way for advancements in treatment options for viral infections.